153 related articles for article (PubMed ID: 34595918)
21. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
22. Significant enhanced expressions of aquaporin-1, -4 and -9 in the brains of various prion diseases.
Shi Q; Wu YZ; Yang X; Xiao K; Maimaitiming A; Gao LP; Chen C; Gao C; Guo Y; Dong XP
Prion; 2019 Jan; 13(1):173-184. PubMed ID: 31814527
[TBL] [Abstract][Full Text] [Related]
23. PrP
Yang W; Chen C; Chen J; Xia Y; Hu C; Wang L; Wu YZ; Shi Q; Chen ZB; Dong XP
Mol Neurobiol; 2022 May; 59(5):3310-3321. PubMed ID: 35303279
[TBL] [Abstract][Full Text] [Related]
24. Stilbene Compounds Inhibit the Replications of Various Strains of Prions in the Levels of Cell Culture, PMCA, and RT-QuIC Possibly via Molecular Binding.
Zhou DH; Wang J; Xiao K; Wu YZ; Maimaitiming A; Hu C; Gao LP; Chen J; Gao C; Chen C; Shi Q; Dong XP
ACS Chem Neurosci; 2020 Jul; 11(14):2117-2128. PubMed ID: 32511904
[TBL] [Abstract][Full Text] [Related]
25. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
26. Aberrant alterations of the expressions and S-nitrosylation of calmodulin and the downstream factors in the brains of the rodents during scrapie infection.
Zhang RQ; Chen C; Xiao LJ; Sun J; Ma Y; Yang XD; Xu XF; Xiao K; Shi Q; Chen ZB; Dong XP
Prion; 2017 Sep; 11(5):352-367. PubMed ID: 28968141
[TBL] [Abstract][Full Text] [Related]
27. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
28. Abnormally upregulated αB-crystallin was highly coincidental with the astrogliosis in the brains of scrapie-infected hamsters and human patients with prion diseases.
Wang K; Zhang J; Xu Y; Ren K; Xie WL; Yan YE; Zhang BY; Shi Q; Liu Y; Dong XP
J Mol Neurosci; 2013 Nov; 51(3):734-48. PubMed ID: 23832485
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
30. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
31. Prion Efficiently Replicates in α-Synuclein Knockout Mice.
Bistaffa E; Rossi M; De Luca CMG; Cazzaniga F; Carletta O; Campagnani I; Tagliavini F; Legname G; Giaccone G; Moda F
Mol Neurobiol; 2019 Nov; 56(11):7448-7457. PubMed ID: 31041657
[TBL] [Abstract][Full Text] [Related]
32. Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics.
Ding M; Teruya K; Zhang W; Lee HW; Yuan J; Oguma A; Foutz A; Camacho MV; Mitchell M; Greenlee JJ; Kong Q; Doh-Ura K; Cui L; Zou WQ
Mol Neurobiol; 2021 Sep; 58(9):4280-4292. PubMed ID: 33983547
[TBL] [Abstract][Full Text] [Related]
33. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.
Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N
Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
36. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
37. Transfer of scrapie prion infectivity by cell contact in culture.
Kanu N; Imokawa Y; Drechsel DN; Williamson RA; Birkett CR; Bostock CJ; Brockes JP
Curr Biol; 2002 Apr; 12(7):523-30. PubMed ID: 11937020
[TBL] [Abstract][Full Text] [Related]
38. A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
Bajsarowicz K; Ahn M; Ackerman L; Dearmond BN; Carlson G; DeArmond SJ
J Neuropathol Exp Neurol; 2012 May; 71(5):449-66. PubMed ID: 22507918
[TBL] [Abstract][Full Text] [Related]
39. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
